By WSJ Staff
President-elect Donald Trump's selection of vaccine skeptic Robert F. Kennedy Jr. as health secretary weighed on global pharmaceutical stocks Friday.
-- In Europe, shares in Bavarian Nordic fell more than 15%. Pharma heavyweights AstraZeneca, GSK and Sanofi dropped 2.5% or more.
-- In the U.S., Moderna stock fell premarket. It and Pfizer dropped Thursday in regular trading, after news of RFK Jr.'s likely appointment emerged.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
November 15, 2024 06:45 ET (11:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments